Fastly ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Encourages Investors to Contact the Firm to Learn More
June 11, 2024 06:30 ET
|
Block & Leviton LLP
A lawsuit was recently filed against Fastly, Inc. Investors who have lost money in their Fastly investment should contact Block & Leviton LLP.
SHAREHOLDER ALERT: Cibus, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
June 10, 2024 11:16 ET
|
Block & Leviton LLP
Cibus, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm.
Cibus Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
June 04, 2024 12:27 ET
|
Block & Leviton LLP
Cibus, Inc. investigated for potential securities law violations. Investors who have lost money in their Cibus investment should contact Block & Leviton.
SHAREHOLDER ALERT: Fastly Sued for Securities Law Violations; Investors Should Contact Block & Leviton To Learn How They Might Recover Their Losses
June 03, 2024 09:38 ET
|
Block & Leviton LLP
A securities fraud lawsuit has been filed against Fastly (FSLY). Investors who have lost money in their Fastly investment should contact Block & Leviton.
Fastly Sued For Securities Violations; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
May 28, 2024 19:21 ET
|
Block & Leviton LLP
Block & Leviton announces a securities fraud lawsuit has been filed against Fastly (NYSE: FSLY). Investors who have lost money should contact the firm.
Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
May 08, 2024 07:00 ET
|
Cingulate Inc.
CTx-1301 on track to file for Marketing Approval with FDA in 1H 2025 Increase of $10 Million in Stockholders’ Equity KANSAS CITY, Kan., May 08, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:...
Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access
April 30, 2024 05:45 ET
|
Cingulate Inc.
KANSAS CITY, Kan., April 30, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
April 01, 2024 08:00 ET
|
Cingulate Inc.
$17.8 Million Raised Since Beginning of 2023$9.1 Million of Debt Converted to Equity at a PremiumPhase 3 ADHD Data Continues to Impress KANSAS CITY, Kan., April 01, 2024 (GLOBE NEWSWIRE) --...
Cingulate to Attend DCAT Week 2024 in New York City
March 06, 2024 06:45 ET
|
Cingulate Inc.
KANSAS CITY, Kan., March 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
February 13, 2024 06:45 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...